Cargando…

Radiomics based on biparametric MRI for the detection of significant residual prostate cancer after androgen deprivation therapy: using whole-mount histopathology as reference standard

We aimed to study radiomics approach based on biparametric magnetic resonance imaging (MRI) for determining significant residual cancer after androgen deprivation therapy (ADT). Ninety-two post-ADT prostate cancer patients underwent MRI before prostatectomy (62 with significant residual disease and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhang-Zhe, Gu, Wei-Jie, Zhou, Bing-Ni, Liu, Wei, Gan, Hua-Lei, Zhang, Yong, Zhou, Liang-Ping, Liu, Xiao-Hang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933973/ https://www.ncbi.nlm.nih.gov/pubmed/35532558 http://dx.doi.org/10.4103/aja202215

Ejemplares similares

Predicting the Grade of Prostate Cancer Based on a Biparametric MRI Radiomics Signature
por: Zhang, Li, et al.
Publicado: (2021)

Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer
por: Tong, Pengfei, et al.
Publicado: (2023)

MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI
por: Chen, Tong, et al.
Publicado: (2022)

The clinical guiding value of a radiomics model for androgen deprivation therapy for prostate cancer
por: Yu, Na, et al.
Publicado: (2021)

A deep learning masked segmentation alternative to manual segmentation in biparametric MRI prostate cancer radiomics
por: Bleker, Jeroen, et al.
Publicado: (2022)

Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer
por: Xu, Lili, et al.
Publicado: (2019)

Short review of biparametric prostate MRI
por: Steinkohl, Fabian, et al.
Publicado: (2018)

A scoring diagnostic system based on biparametric ultrasound features for prostate cancer risk assessment
por: Liu, Xiu, et al.
Publicado: (2023)

Single-center versus multi-center biparametric MRI radiomics approach for clinically significant peripheral zone prostate cancer
por: Bleker, Jeroen, et al.
Publicado: (2021)

Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL
por: Lu, Yangbai, et al.
Publicado: (2022)

Biparametric Quantitative MRI for Prostate Cancer Detection
por: Uyanik, Meltem, et al.
Publicado: (2023)

Androgen deprivation therapy and the risk of subsequent keratitis
por: Liu, Dai-Wei, et al.
Publicado: (2020)

Biparametric versus multiparametric MRI in the diagnosis of prostate cancer
por: Thestrup, Karen Cecilie Duus, et al.
Publicado: (2016)

Radiogenomics Reveals Correlation between Quantitative Texture Radiomic Features of Biparametric MRI and Hypoxia-Related Gene Expression in Men with Localised Prostate Cancer
por: Ogbonnaya, Chidozie N., et al.
Publicado: (2023)

Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study
por: Boesen, Lars, et al.
Publicado: (2018)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
por: Jin, Pengfei, et al.
Publicado: (2022)

A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy
por: Kasparian, Saro, et al.
Publicado: (2023)

Detection of intermediate- and high-risk prostate cancer with biparametric magnetic resonance imaging: a systematic review and meta-analysis
por: Wang, Yajing, et al.
Publicado: (2023)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database
por: Jambor, Ivan, et al.
Publicado: (2021)

Current Status of Biparametric MRI in Prostate Cancer Diagnosis: Literature Analysis
por: Belue, Mason James, et al.
Publicado: (2022)

AI-assisted biparametric MRI surveillance of prostate cancer: feasibility study
por: Roest, C., et al.
Publicado: (2022)

Could Biparametric MRI Replace Multiparametric MRI in the Management of Prostate Cancer?
por: Iacob, Roxana, et al.
Publicado: (2023)

Crosstalk between apoptosis and autophagy in prostate epithelial cells under androgen deprivation
por: Liu, Rong-Fu, et al.
Publicado: (2018)

Isotropic Expansion of the Intraprostatic Gross Tumor Volume of Primary Prostate Cancer Patients Defined in MRI—A Correlation Study With Whole Mount Histopathological Information as Reference
por: Kramer, Maria, et al.
Publicado: (2020)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Androgen deprivation-induced OPHN1 amplification promotes castration-resistant prostate cancer
por: Liu, Junjiang, et al.
Publicado: (2022)

Deep Learning in Prostate Cancer Diagnosis Using Multiparametric Magnetic Resonance Imaging With Whole-Mount Histopathology Referenced Delineations
por: Li, Danyan, et al.
Publicado: (2022)

Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
por: Li, Xuwen, et al.
Publicado: (2023)

Flat mount preparation for whole-mount fluorescent imaging of zebrafish embryos
por: Frommelt, Joseph, et al.
Publicado: (2023)

Reliability of whole mount radical prostatectomy histopathology as the ground truth for artificial intelligence assisted prostate imaging
por: Jager, Auke, et al.
Publicado: (2023)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
por: Bassey, Iya Eze, et al.
Publicado: (2020)

Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making
por: Pan, Jin-feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_10ug63gqb73n8m9en7k1h9a8c8